These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 5137653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Resistance effect to the para-amino-salicylic acid and the isoniazid phenyl-para-amino-salicylate].
    Torning K.
    Prensa Med Argent; 1966; 53(9):1055-9. PubMed ID: 6004190
    [No Abstract] [Full Text] [Related]

  • 7. Tolerance to cycloserine.
    Riska N.
    Scand J Respir Dis Suppl; 1970; 71():209-16. PubMed ID: 5271988
    [No Abstract] [Full Text] [Related]

  • 8. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A, Borgå O, Sjöqvist F.
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract] [Full Text] [Related]

  • 9. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B, Bisetti A, Monzali G.
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract] [Full Text] [Related]

  • 10. [The para-aminosalicylic acid (PAS) level of the venous blood in patients after the administration of various PAS preparations for pulmonary tuberculosis].
    Kreukniet J, Tasman A, Bangma PJ.
    Ned Tijdschr Geneeskd; 1965 Sep 18; 109(38):1760-1. PubMed ID: 5317952
    [No Abstract] [Full Text] [Related]

  • 11. [Concentration in the blood and excretion of para-aminosalicylic acid and its metabolites after intake of BEPAS preparation].
    Savula MM.
    Probl Tuberk; 1973 Sep 18; 51(10):44-7. PubMed ID: 4784037
    [No Abstract] [Full Text] [Related]

  • 12. [Comparative study of therapeutic effect and side actions of 1314 TH and 1321 TH in the initial therapy of tuberculosis].
    Sunahara S, Nagasawa S.
    Saishin Igaku; 1969 Apr 18; 24(4):922-7. PubMed ID: 5807960
    [No Abstract] [Full Text] [Related]

  • 13. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J.
    Scand J Respir Dis; 1969 Apr 18; 50(3):169-85. PubMed ID: 5195904
    [No Abstract] [Full Text] [Related]

  • 14. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ, Ayanoglu-Dülger G, Ulusoy NB, Imeryüz N.
    Int J Clin Pharmacol Ther; 1998 Oct 18; 36(10):549-53. PubMed ID: 9799060
    [Abstract] [Full Text] [Related]

  • 15. [Effect of sodium para-aminosalicylate on the concentration of isoniazid (tubazid) in the blood of patients with tuberculosis].
    Kozulitsina TI, Korotaev GA.
    Ter Arkh; 1969 Oct 18; 41(10):94-7. PubMed ID: 5359356
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Important metabolic disorders due to the administration of para aminosalicylic acid].
    Miquel Servert J, Jareño Chaumel A, Oteo De La Vara B, Pérez Peña F, De Elio Membrado FJ.
    Rev Clin Esp; 1978 Mar 31; 148(6):631-41. PubMed ID: 663343
    [No Abstract] [Full Text] [Related]

  • 18. [The treatment of inflammatory intestinal diseases with preparations of 5-aminosalicylic acid].
    Frol'kis AV.
    Ter Arkh; 1996 Mar 31; 68(2):75-7. PubMed ID: 8771669
    [No Abstract] [Full Text] [Related]

  • 19. Resin-coated 5-aminosalicylic acid (Asacol) in rheumatoid arthritis.
    Situnayake RD, McConkey B.
    Br J Rheumatol; 1985 May 31; 24(2):226-7. PubMed ID: 3995220
    [No Abstract] [Full Text] [Related]

  • 20. [Studies of gastric tolerance of coated alka-butazolidin tablets].
    Richter H, Atefie K, Gangl A, Thumb N.
    Wien Z Inn Med; 1970 May 31; 51(9):430-6. PubMed ID: 5316365
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.